PYCR1 and pancreatic neoplasm: Using PROGgene V2 and survival analysis with the GSE21501 dataset, we found that concurrent high expression of FTH1 and PYCR1 correlated with poorer survival in human pancreatic cancer patients, as shown in Supplementary Fig. 6b.